IM Cannabis (IMCC) Cash & Current Investments (2019 - 2026)
IM Cannabis (IMCC) posted quarterly Cash & Current Investments of $840045.0 for Q1 2026, down 64.6% quarter-over-quarter from $2.4 million in Q4 2025.
IM Cannabis (IMCC) Cash & Current Investments (2019 - 2026) Analysis & Trends
IM Cannabis' Cash & Current Investments history runs 8 years deep, the most recent figure standing at $840045.0 for Q1 2026.
- In Q1 2026, Cash & Current Investments changed N/A year-over-year to $840045.0; the TTM figure through Mar 2026 stood at $840045.0 (changed N/A YoY), while the FY2025 annual figure was $2.4 million, up 30.26% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $840045.0, down from $2.4 million in the prior quarter.
- The five-year high for Cash & Current Investments was $12.1 million in Q1 2022, with the low at $601908.2 in Q2 2025.
- The 5-year median for Cash & Current Investments is $2.2 million (2023), against an average of $3.0 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments soared 90.14% in 2022, then slumped 78.17% in 2023.
- IM Cannabis' Cash & Current Investments stood at $3.6 million in 2022, then slipped by 15.91% to $3.0 million in 2023, then tumbled by 40.69% to $1.8 million in 2024, then jumped by 32.91% to $2.4 million in 2025, then tumbled by 64.6% to $840045.0 in 2026.
- Business Quant data shows IMCC's Cash & Current Investments at $840045.0 in Q1 2026, $2.4 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 164.00 Mn |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.60 Mn |
| Mar 31, 2026 | 840,044.96 |
| Dec 31, 2025 | 2.37 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 601,908.22 |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2022 | 3.58 Mn |
| Sep 30, 2022 | 3.12 Mn |
| Jun 30, 2022 | 6.97 Mn |
| Mar 31, 2022 | 12.13 Mn |
| Dec 31, 2021 | 11.04 Mn |
| Jun 30, 2021 | 29.96 Mn |
| Mar 31, 2021 | 6.38 Mn |